PubMed:23591271
|
High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects.
|
projects
| Unselected / annnotation | Selected / annnotation | |
|
|
|
|
|
High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects.
|
| Unselected / annnotation | Selected / annnotation | |
|
|
|
|